XML 23 R8.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Dec. 31, 2018
Mar. 31, 2019
Dec. 31, 2018
Mar. 31, 2018
Operating activities:            
Net income $ 62,900 $ 61,022        
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization 85,395 90,383        
Debt premium and discount amortization 468 (952)        
Deferred financing cost amortization 1,787 1,682        
Accretion of above- and below-market leases, net (4,898) (6,824)        
Provisions for impairment 3,112 15,902        
Gain on disposition of operating properties (7,602) (11,448)        
Equity based compensation 2,641 2,484        
Other 827 824        
(Gain) loss on extinguishment of debt, net (30) 132        
Changes in operating assets and liabilities:            
Receivables (816) 12,171        
Deferred charges and prepaid expenses (6,829) (5,309)        
Other assets 82 40        
Accounts payable, accrued expenses and other liabilities (40,199) (35,657)        
Net cash provided by operating activities 96,838 124,450        
Investing activities:            
Improvements to and investments in real estate assets (77,725) (76,803)        
Proceeds from sales of real estate assets 45,160 104,198        
Purchase of marketable securities (5,246) (3,655)        
Proceeds from sale of marketable securities 5,977 4,496        
Net cash provided by (used in) investing activities (31,834) 28,236        
Financing activities:            
Repayment of secured debt obligations 0 (4,858)        
Repayment of borrowings under unsecured revolving credit facility (65,000) 0        
Proceeds from borrowings under unsecured revolving credit facility 50,000 0        
Repayment of borrowings under unsecured term loans 0 (50,000)        
Deferred financing and debt extinguishment costs (133) (184)        
Distributions to common stockholders (84,097) (84,165)        
Repurchases of common shares (11,586) (29,765)        
Repurchases of common shares in conjunction with equity award plans (1,547) (1,722)        
Net cash used in financing activities (112,363) (170,694)        
Net change in cash, cash equivalents and restricted cash (47,359) (18,008)        
Cash, cash equivalents and restricted cash at beginning of period 50,765 110,777 $ 110,777      
Cash, cash equivalents and restricted cash at end of period 3,406 92,769 50,765      
Reconciliation to consolidated balance sheets:            
Cash and cash equivalents 349 27,332 41,745      
Restricted cash       $ 3,057 $ 9,020 $ 65,437
Cash, cash equivalents and restricted cash at end of period 50,765 110,777 110,777 3,406 50,765 92,769
Supplemental disclosure of cash flow information:            
Cash paid for interest, net of amount capitalized of $626 and $654 51,168          
Brixmor Operating Partnership LP            
Operating activities:            
Net income 62,900 61,022        
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization 85,395 90,383        
Debt premium and discount amortization 468 (952)        
Deferred financing cost amortization 1,787 1,682        
Accretion of above- and below-market leases, net (4,898) (6,824)        
Provisions for impairment 3,112 15,902        
Gain on disposition of operating properties (7,602) (11,448)        
Equity based compensation 2,641 2,484        
Other 827 824        
(Gain) loss on extinguishment of debt, net (30) 132        
Changes in operating assets and liabilities:            
Receivables (816) 12,171        
Deferred charges and prepaid expenses (6,829) (5,309)        
Other assets 82 40        
Accounts payable, accrued expenses and other liabilities (40,199) (35,657)        
Net cash provided by operating activities 96,838 124,450        
Investing activities:            
Improvements to and investments in real estate assets (77,725) (76,803)        
Proceeds from sales of real estate assets 45,160 104,198        
Purchase of marketable securities (5,245) (3,654)        
Proceeds from sale of marketable securities 5,977 4,496        
Net cash provided by (used in) investing activities (31,833) 28,237        
Financing activities:            
Repayment of secured debt obligations 0 (4,858)        
Repayment of borrowings under unsecured revolving credit facility (65,000) 0        
Proceeds from borrowings under unsecured revolving credit facility 50,000 0        
Repayment of borrowings under unsecured term loans 0 (50,000)        
Deferred financing and debt extinguishment costs (133) (184)        
Partner distributions (97,355) (115,652)        
Net cash used in financing activities (112,488) (170,694)        
Net change in cash, cash equivalents and restricted cash (47,483) (18,007)        
Cash, cash equivalents and restricted cash at beginning of period 50,639 110,747 110,747      
Cash, cash equivalents and restricted cash at end of period 3,156 92,740 50,639      
Reconciliation to consolidated balance sheets:            
Cash and cash equivalents 99 27,303 41,619      
Restricted cash       3,057 9,020 65,437
Cash, cash equivalents and restricted cash at end of period $ 50,639 110,747 $ 110,747 $ 3,156 $ 50,639 $ 92,740
Supplemental disclosure of cash flow information:            
Cash paid for interest, net of amount capitalized of $626 and $654   $ 63,646